Insight of current technologies for oral delivery of proteins and peptides
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chin, J. | - |
dc.contributor.author | Foyez, Mahmud K.A. | - |
dc.contributor.author | Kim, S.E. | - |
dc.contributor.author | Park, K. | - |
dc.contributor.author | Byun, Y. | - |
dc.date.accessioned | 2021-10-13T02:40:39Z | - |
dc.date.available | 2021-10-13T02:40:39Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 1740-6749 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50183 | - |
dc.description.abstract | Although significant progress has been made in developing oral formulations to deliver bioactive proteins and peptide therapeutics, oral routes still need to overcome formidable barriers such as poor stability and permeability and rapid enzymatic degradation. Thus, novel formulation technologies for oral delivery of proteins and peptides are needed to further improve the bioavailability and therapeutic efficacy. In recent decades, researchers have attempted different strategies to successfully deliver proteins orally. In this review, we examine the current technologies being developed for protein and peptide oral delivery. © 2012 Elsevier Ltd. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier Ltd | - |
dc.title | Insight of current technologies for oral delivery of proteins and peptides | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.ddtec.2012.04.005 | - |
dc.identifier.bibliographicCitation | Drug Discovery Today: Technologies, v.9, no.2, pp e105 - e112 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84873081796 | - |
dc.citation.endPage | e112 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | e105 | - |
dc.citation.title | Drug Discovery Today: Technologies | - |
dc.citation.volume | 9 | - |
dc.type.docType | Review | - |
dc.publisher.location | 네델란드 | - |
dc.subject.keywordPlus | calcitonin | - |
dc.subject.keywordPlus | human growth hormone | - |
dc.subject.keywordPlus | human insulin | - |
dc.subject.keywordPlus | hybrid protein | - |
dc.subject.keywordPlus | insulin | - |
dc.subject.keywordPlus | liposome | - |
dc.subject.keywordPlus | metformin | - |
dc.subject.keywordPlus | nanocarrier | - |
dc.subject.keywordPlus | parathyroid hormone[1-34] | - |
dc.subject.keywordPlus | peptides and proteins | - |
dc.subject.keywordPlus | pioglitazone | - |
dc.subject.keywordPlus | recombinant human insulin | - |
dc.subject.keywordPlus | recombinant parathyroid hormone | - |
dc.subject.keywordPlus | sulfonylurea derivative | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cell engineering | - |
dc.subject.keywordPlus | cross linking | - |
dc.subject.keywordPlus | crystallization | - |
dc.subject.keywordPlus | drug absorption | - |
dc.subject.keywordPlus | drug delivery system | - |
dc.subject.keywordPlus | drug formulation | - |
dc.subject.keywordPlus | drug transport | - |
dc.subject.keywordPlus | enzymatic degradation | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | liposomal delivery | - |
dc.subject.keywordPlus | microemulsion | - |
dc.subject.keywordPlus | molecular library | - |
dc.subject.keywordPlus | mucoadhesion | - |
dc.subject.keywordPlus | non insulin dependent diabetes mellitus | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | tablet formulation | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.